Notice of Privacy Incident
Medicaid Provider Termination Alert: Revalidation deadlines are approaching. Failure by providers to revalidate will lead to termination and payment suspension. Check your account now at https://impact.illinois.gov/ to learn if your required revalidation is due this month. More revalidation information here.

Drugs and Therapeutics (D & T) Committee Meeting Results for: December 03, 2008

Drug Name	Review Type	Committee Recommendation	Prior Approval Status � Final Determination
Alvesco	New Drug Initial Review	Remove Prior Approval Requirement	Prior Approval Required
Keppra XR	New Drug Initial Review	Require Prior Approval	Prior Approval Required
Venlafaxine ER	New Drug Initial Review	Require Prior Approval	Prior Approval Required
Pataday	New Drug Initial Review	Remove Prior Approval Requirement	Prior Approval Requirement Removed
Factive	New Drug Appeal	Require Prior Approval	Prior Approval Required
Patanase	New Drug Appeal	Remove Prior Approval Requirement	Prior Approval Requirement Removed
Altabax	New Drug Appeal	Require Prior Approval	Prior Approval Required
Ranexa	New Drug Appeal	Require Prior Approval	Prior Approval Required
Suprax Suspension	PDL Appeal	Require Prior Approval	Prior Approval Required

Footer